Ratings by Evercore ISI (Umer Raffat)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/10/2021 Organon & Co. OGN New Coverage Outperform
(N/A)
28.45
(29.77)
4.64% Details
3/12/2021 Kodiak Sciences Inc. KOD New Coverage Outperform
(N/A)
126.89
(88.02)
-30.63% Details
12/8/2020 Mirati Therapeutics MRTX New Coverage Outperform
(N/A)
233.26
(162.46)
-30.35% Details
11/25/2020 Atea Pharmaceuticals AVIR New Coverage Outperform
(N/A)
34.07
(23.42)
-31.26% Details
11/23/2020 Arcus Biosciences RCUS New Coverage Outperform
(N/A)
24.38
(27.02)
10.83% Details
7/14/2020 Royalty Pharma RPRX New Coverage In Line
(N/A)
47.64
(43.03)
-9.68% Details
1/21/2020 Amgen AMGN Upgrade Outperform
(In Line)
241.49
(240.95)
-0.22% Details
11/20/2019 Phathom Pharmaceuticals PHAT New Coverage Outperform
(N/A)
24.27
(35.05)
44.42% Details
8/7/2019 Teva Pharma TEVA Downgrade In Line
(Outperform)
7.06
(10.42)
47.59% Details
7/2/2019 Dova Pharmaceuticals Inc DOVA Upgrade Outperform
(In Line)
14.10
(28.04)
98.87% Details
1/28/2019 Amgen AMGN Downgrade In Line
(Outperform)
200.97
(241.49)
20.16% Details
11/16/2018 Molecular Templates MTEM New Coverage Outperform
(N/A)
4.40
(8.50)
93.18% Details
8/24/2018 Mylan MYL Upgrade Outperform
(In Line)
37.86
(15.86)
-58.11% Details
8/13/2018 Teva Pharma TEVA Maintain Outperform
(N/A)
 
 
  Details